PTEN Regulates Mitochondrial Biogenesis via the AKT/GSK-3β/PGC-1α Pathway in Autism
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 465, 85-94
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 39 references indexed in Scilit:
- Nuclear Excluded Autism-Associated Phosphatase and Tensin Homolog Mutations Dysregulate Neuronal GrowthBiological Psychiatry, 2018
- Synaptic Wnt/GSK3βSignaling Hub in AutismNeural Plasticity, 2016
- Tuberous Sclerosis: A New Frontier in Targeted Treatment of AutismNeurotherapeutics, 2015
- Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismNeuroscience & Biobehavioral Reviews, 2014
- PTENCommunicative & Integrative Biology, 2014
- Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral testsHuman Molecular Genetics, 2014
- Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic StateCell, 2012
- Genetics and Mitochondrial Abnormalities in Autism Spectrum Disorders:A ReviewCurrent Genomics, 2011
- Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephalyAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- PTEN couples Sema3A signalling to growth cone collapseJournal of Cell Science, 2006